Aquestive Therapeutics (AQST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2024, Aquestive Therapeutics (AQST) reported revenue of $20.1 million, up 51.8% over the same period last year. EPS came in at -$0.03, compared to -$0.10 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $12.62 million, representing a surprise of +59.31%. The company delivered an EPS surprise of +72.73%, with the consensus EPS estimate being -$0.11.While investors scrutinize revenue and earnings changes year-over-year and how they compare wit ...